Aurora Cannabis (ACB) Upgraded at ValuEngine

Aurora Cannabis (NYSE:ACB) was upgraded by equities research analysts at ValuEngine from a “hold” rating to a “buy” rating in a report released on Tuesday.

Several other research firms have also recently weighed in on ACB. GMP Securities raised shares of Aurora Cannabis from a “hold” rating to a “buy” rating in a research note on Wednesday, March 13th. TheStreet cut shares of Aurora Cannabis from a “c” rating to a “d+” rating in a research note on Monday, February 25th. Cowen assumed coverage on shares of Aurora Cannabis in a research note on Tuesday, March 5th. They issued an “outperform” rating for the company. Seaport Global Securities assumed coverage on shares of Aurora Cannabis in a research note on Thursday, February 21st. They issued a “neutral” rating for the company. Finally, Jefferies Financial Group assumed coverage on shares of Aurora Cannabis in a research note on Monday, February 25th. They issued a “buy” rating for the company. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus target price of $9.50.

Aurora Cannabis stock opened at $9.81 on Tuesday. Aurora Cannabis has a 1-year low of $4.05 and a 1-year high of $12.52. The company has a debt-to-equity ratio of 0.08, a current ratio of 3.31 and a quick ratio of 2.50. The company has a market capitalization of $10.08 billion, a PE ratio of 81.75 and a beta of 2.90.

Aurora Cannabis (NYSE:ACB) last posted its quarterly earnings results on Monday, February 11th. The company reported ($0.04) earnings per share for the quarter, beating the consensus estimate of ($0.06) by $0.02. Aurora Cannabis had a negative net margin of 57.54% and a positive return on equity of 3.95%. The business had revenue of $41.00 million during the quarter. As a group, equities analysts forecast that Aurora Cannabis will post -0.17 earnings per share for the current fiscal year.

Large investors have recently bought and sold shares of the stock. Flagship Harbor Advisors LLC purchased a new position in shares of Aurora Cannabis during the 4th quarter worth approximately $26,000. Advisory Services Network LLC purchased a new position in shares of Aurora Cannabis during the 4th quarter worth approximately $29,000. Trustcore Financial Services LLC purchased a new position in shares of Aurora Cannabis during the 4th quarter worth approximately $33,000. Farmers & Merchants Trust Co of Chambersburg PA purchased a new position in shares of Aurora Cannabis during the 4th quarter worth approximately $36,000. Finally, Beutel Goodman & Co Ltd. purchased a new position in shares of Aurora Cannabis during the 4th quarter worth approximately $37,000. 8.05% of the stock is owned by hedge funds and other institutional investors.

About Aurora Cannabis

Aurora Cannabis Inc produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.

Featured Story: Intrinsic Value

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.